Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Muscle Invasive Bladder Cancer (MIBC) × Gemcitabine × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Pancreatic Neoplasms 590 Carcinoma, Non-Small-Cell Lung 277 Breast Neoplasms 142 Neoplasms 138 Lung Neoplasms 134 Urinary Bladder Neoplasms 132 Neoplasm Metastasis 116 Cholangiocarcinoma 95 Ovarian Neoplasms 84 Biliary Tract Neoplasms 80 Nasopharyngeal Carcinoma 64 Lymphoma, Large B-Cell, Diffuse 64 Lymphoma 56 Sarcoma 54 Recurrence 54 Gallbladder Neoplasms 53 Carcinoma, Transitional Cell 45 Hodgkin Disease 44 Colorectal Neoplasms 42 Triple Negative Breast Neoplasms 41 Lymphoma, Non-Hodgkin 41 Fallopian Tube Neoplasms 39 Adenocarcinoma 39 Bile Duct Neoplasms 36 Non-Muscle Invasive Bladder Neoplasms 27 Carcinoma 27 Uterine Cervical Neoplasms 26 Carcinoma, Ovarian Epithelial 26 Unspecified Adult Solid Tumor, Protocol Specific 24 Urethral Neoplasms 22

Interventions

zanidatamab 1 toripalimab 1 tislelizumab 1 disitamab vedotin 1 Probiotics 1 Gemcitabine 1 Cisplatin 1 130-nm albumin-bound paclitaxel 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07296705 2025-12-22

HARBOR

Fujian Medical University Union Hospital

Phase 2 Recruiting

Muscle Invasive Bladder Cancer (MIBC)

Data powered by HemOnc (CC BY 4.0) Colophon ⚡